TQB2223

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB2223, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of TQB2223 Injection Combined With AK105 Injection in the Treatment of Advanced Hepatocellular Carcinoma. [Phase 1]

See pricing